Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Despite One Death and One Adverse Event, bluebird bio's Gene Therapy Study Meets Goals October 4, 2017 Meet the 4 Biotechs That are Disrupting Healthcare November 13, 2017 Medtech Innovative Health Solutions to Create New Jobs in Expansion November 20, 2017
Despite One Death and One Adverse Event, bluebird bio's Gene Therapy Study Meets Goals October 4, 2017